The US Oncology Network | Association Partnerships

July 23, 2022

Bradley Monk, MD, FACCOG, FACS, discusses main takeaways from the OUTBACK trial of adjuvant chemotherapy following chemoradiation as primary treatment in patients with locally advanced cervical cancer vs chemoradiation alone.

June 29, 2022

Kruti Patel, DO, reviews the advancements, landmark trials, and challenges with CAR T-cell therapy for Cancer Immunotherapy Month.

June 23, 2022

During an interview with Targeted Oncology, Nicholas J. Robert, MD, further discussed the data of the MYLUNG study which he presented in a poster at the 2022 American Society of Clinical Oncology Annual Meeting.

June 06, 2022

Patients with platinum-sensitive ovarian cancer treated with maintenance rucaparib in the ATHENA-MONO trial showed a significant improvement in progression-free survival when compared with placebo in the first-line setting, regardless of HRD status.

March 20, 2022

Given the rapid pace of advancements in the diagnosis and treatment of prostate cancer, the greatest challenge may be coordinating these advances and applying them to disease management.

February 22, 2022

Bradley Monk, MD, FACCOG, FACS, discusses the creation and findings of the OUTBACK trial.